newsfilter
← Latest News
Business Wire·

ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2012 Financial Results

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced financial results for the year and quarter ended December 31, 2012.